GSK Financials: Revenue & Earnings
GSK$48.52-0.23 -0.46%
$97.35B
Market Cap
15.96
P/E
13.41
Forward P/E
55
Score
GSK Financials: Revenue & Earnings
GSK price $48.52 -0.23 -0.46%
- Ticker
- GSK
- Price
- $48.52
- Change
- -0.23 -0.46%
- Market cap ?
- $97.35B
- P/E ?
- 15.96
- Forward P/E ?
- 13.41
- Dividend yield ?
- 3.55%
- Beta ?
- 0.28
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 55
- Value
- 56
- Quality
- 67
- Growth
- 42
Stocklytics score rationale: value 56, quality 67, growth 42.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 27889000000 | 30186000000 | 30821000000 | 33754000000 | 24354000000 | 24696000000 | 29324000000 | 30328000000 | 31376000000 | 32667000000 |
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines…
Earnings and financials
GSK plc (GSK) trades at $48.52, with a market cap of $97.35B and a trailing P/E of 15.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 27889000000 | 30186000000 | 30821000000 | 33754000000 | 24354000000 | 24696000000 | 29324000000 | 30328000000 | 31376000000 | 32667000000 |
Insights · Dividends · Forecast · Financials · Learn